Latest News
More News
-
.jpg)
Potential cure for peripheral artery disease 27 August 2024 Ground-breaking results from researchers at Sir Charles Gairdner Hospital (SCGH) aims to enhance the outcomes for patients with Peripheral artery disease (PAD). PAD is a common condition affecting more than 230 million people worldwide. It involves narrowed arteries reducing blood flow most commonly to the legs and other vital organs. PAD is caused by a build-up of fatty, cholesterol-containing deposits or plaques on artery walls. Currently, around two thirds of people with end stage advanced PAD will require an amputation and approximately a fifth will have a cardiac event, such as a heart attack, in their lifetime. Vascular surgeon and Head of Department of Vascular and Endovascular Surgery at SCGH Professor Shirley Jansen and Associate Professor Juliana Hamzah have found success in a new drug that will change the trajectory of people suffering with advanced PAD. After an accumulation ... -
New outpatient Prehabilitation service 26 August 2024 A new Prehabilitation service has been launched for patients receiving treatment at Sir Charles Gairdner and Osborne Park Hospitals with the aim to improve patients physical, nutritional, and psychological health prior to complex surgery or stem cell transplant. The Prehabilitation service is a pre-surgical multidisciplinary team providing physiotherapy, dietetics, and clinical psychology for outpatients. Prehabilitation benefits include optimised physical and psychological readiness for surgery, reduced length of hospital stay, improved post-surgical functioning for the patient and more. Find out more. -
New treatment options inspire innovative medical research 22 August 2024 A passion for driving increased access to the latest treatments for WA patients with lymphoma and other blood cancers has guided Professor Chan Cheah in his first investigator-initiated trial, LEVERAGE. LEVERAGE is a phase I/II clinical trial looking into the potential of non-chemotherapy treatment for advanced stage follicular lymphoma patients. Due to the significant undesirable side effects of chemotherapy, a combination of 3 non-chemotherapy medications – obinutuzumab, lenalidomide and venetoclax – is being reviewed to assess whether they can be part of a treatment that is effective and has a more favourable side effect profile. Prof Cheah, Clinical Haematologist at Sir Charles Gairdner Hospital, said that the idea of the project came to him when he was out for a run in 2016. Interim results from the study have been positive with 91 per cent of the 45 patients responding ... -
Celebrating Kerry's 60-year career 19 July 2024 Sir Charles Gairdner Hospital (SCGH) farewelled Kerry Mordaunt last week, a true nursing pioneer in Western Australia, who devoted 60 years of service to the community, the majority of that time at SCGH. Kerry, who may also be the longest-standing registered nurse in WA, completed her last shift in the SCGH Respiratory Medicine Department on 9 July after spending the past 17 years in the Department. Kerry commenced her nursing training at SCGH in 1964 and has worked in a variety of roles at the hospital. On the completion of her training Kerry moved to New South Wales where she worked as a theatre nurse for seven years before returning to SCGH in 1974 as a Relieving Charge Nurse before moving into the Coordinator of Nursing Management role in 1987. Highlights included opening the first oncology unit in the state, commissioning the opening of SCGH’s G Block Theatres and being part o... -
Electronic prescribing implementation 12 June 2024 The North Metropolitan Health Service (NMHS) is in the process of implementing electronic prescriptions (external site)in the Outpatient Clinics at Sir Charles Gairdner (SCGH) and Osborne Park Hospitals (OPH). This project will align the SCGOPH care group with the other health service providers in Western Australia, providing patients with access to electronic prescriptions across the state. Instead of receiving a paper prescription, patients can instead opt to receive their prescription via SMS or email. This can then be filled at their local pharmacy. Please note, SCGH and OPH onsite Outpatient Pharmacies are currently unable to receive electronic prescriptions and must still be provided with normal paper prescriptions at present. Patients can also speak to their local community pharmacist about registering for an Active Script List (ASL) which allows their scripts to be stored in a ce...
Last Updated:
12/04/2021